Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2-(2-(diethylamino)ethoxy)ethyl-2-phenylbutyrate Citrate
2. 2-(2-diethylaminoethoxy)ethyl-2-phenylbutamyrate Dihydrogen Citrate
3. Butamirate
4. Butamyrate Citrate
5. Hh 197
6. Sinecod
1. 18109-81-4
2. Abbott 36581
3. Butamirate Citrate [usan]
4. Hh 197
5. Hh-197
6. Abbott-36581
7. Butamirate (citrate)
8. Acodeen
9. Sincodeen
10. Sincodin
11. Sincodix
12. Sinecod
13. 2-(2-(diethylamino)ethoxy)ethyl 2-phenylbutyrate Citrate (1:1)
14. 67hp51l98r
15. 2-[2-(diethylamino)ethoxy]ethyl 2-phenylbutanoate;2-hydroxypropane-1,2,3-tricarboxylic Acid
16. Sincodex
17. Butamirate Citrate (usan)
18. Butamyrate Citrate
19. Dsstox_cid_26270
20. Dsstox_rid_81497
21. Dsstox_gsid_46270
22. Cas-18109-81-4
23. Einecs 242-006-8
24. Unii-67hp51l98r
25. Oxeladin Impurity D
26. 2-(2-(diethylamino)ethoxy)-ethyl 2-phenylbutyrate Citrate
27. Phenyl Acetic Acid Diethylaminoethoxyethanol Ester Citrate
28. 2-phenylbutyric Acid 2-(2-(diethylamino)ethoxy)ethyl Ester Citrate
29. Butamirate-[d5] Citrate
30. Alpha-ethylbenzeneacetic Acid 2-(2-(diethylamino)ethoxy)ethyl Ester Citrate
31. Schembl636120
32. Butamirate Citrate [mi]
33. Chembl2106133
34. Dtxsid0046270
35. Butamirate Citrate [mart.]
36. Bcp22355
37. Butamirate Citrate [who-dd]
38. Tox21_111952
39. Stk069532
40. Akos005390008
41. Diethyl(2-(2-(2-phenylbutyroyloxy)ethoxy)ethyl)ammonium Dihydrogencitrate
42. Tox21_111952_1
43. Butyric Acid, 2-phenyl-, 2-(2-(diethylamino)ethoxy)ethyl Ester, Citrate
44. Ncgc00160645-02
45. Alpha-ethylbenzeneacetic Acid, 2-(2-(diethylamino)ethoxy)ethyl Ester, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
46. Benzeneacetic Acid, Alpha-ethyl-2-(2-(diethylamino)ethoxy)ethyl Ester, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
47. Ft-0663922
48. Ft-0663923
49. D03184
50. J-011560
51. Q27264132
52. Alpha-(ethyl)benzeneacetic Acid 2-[2-(diethylamino)ethoxy]ethyl Ester
53. 2-[2-(diethylamino)ethoxy]ethyl 2-phenylbutanoate 2-hydroxypropane-1,2,3-tricarboxylate (salt)
54. Benzeneacetic Acid, .alpha.-ethyl-2-(2-(diethylamino)ethoxy)ethyl Ester, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
| Molecular Weight | 499.6 g/mol |
|---|---|
| Molecular Formula | C24H37NO10 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 11 |
| Rotatable Bond Count | 17 |
| Exact Mass | 499.24174638 g/mol |
| Monoisotopic Mass | 499.24174638 g/mol |
| Topological Polar Surface Area | 171 Ų |
| Heavy Atom Count | 35 |
| Formal Charge | 0 |
| Complexity | 513 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
Regulatory Info : Generic
Registration Country : Turkey
Brand Name :
Dosage Form : Syrup
Dosage Strength : 7.5MG/5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : Turkey
Regulatory Info :
Registration Country : Sweden
Brand Name : Tinguri
Dosage Form : SYRUP
Dosage Strength : 1.5 MG / ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Turkey
Brand Name : TUSAMOL
Dosage Form : Syrup
Dosage Strength : 7.5MG/5ML
Packaging : 100 ml Glass Bottle
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Turkey
Regulatory Info :
Registration Country : Ukraine
butamirate citrate; Guaifenesin
Brand Name : Pectolvan STOP
Dosage Form : Oral Drops
Dosage Strength :
Packaging : 25ML Glass Bottle
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Ukraine
Regulatory Info :
Registration Country : Poland
Brand Name : Natussic
Dosage Form : Syrup
Dosage Strength : 7.5MG/5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Poland
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
Regulatory Info :
Registration Country : Sweden
Brand Name : Tinguri
Dosage Form : SYRUP
Dosage Strength : 1.5 MG / ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Ukraine
butamirate citrate; Guaifenesin
Brand Name : Pectolvan STOP
Dosage Form : Oral Drops
Dosage Strength :
Packaging : 25ML Glass Bottle
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Ukraine
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
A Butamirate Citrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Butamirate Citrate, including repackagers and relabelers. The FDA regulates Butamirate Citrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Butamirate Citrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Butamirate Citrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Butamirate Citrate supplier is an individual or a company that provides Butamirate Citrate active pharmaceutical ingredient (API) or Butamirate Citrate finished formulations upon request. The Butamirate Citrate suppliers may include Butamirate Citrate API manufacturers, exporters, distributors and traders.
click here to find a list of Butamirate Citrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Butamirate Citrate written confirmation (Butamirate Citrate WC) is an official document issued by a regulatory agency to a Butamirate Citrate manufacturer, verifying that the manufacturing facility of a Butamirate Citrate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Butamirate Citrate APIs or Butamirate Citrate finished pharmaceutical products to another nation, regulatory agencies frequently require a Butamirate Citrate WC (written confirmation) as part of the regulatory process.
click here to find a list of Butamirate Citrate suppliers with Written Confirmation (WC) on PharmaCompass.
Butamirate Citrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Butamirate Citrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Butamirate Citrate GMP manufacturer or Butamirate Citrate GMP API supplier for your needs.
A Butamirate Citrate CoA (Certificate of Analysis) is a formal document that attests to Butamirate Citrate's compliance with Butamirate Citrate specifications and serves as a tool for batch-level quality control.
Butamirate Citrate CoA mostly includes findings from lab analyses of a specific batch. For each Butamirate Citrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Butamirate Citrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Butamirate Citrate EP), Butamirate Citrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Butamirate Citrate USP).
LOOKING FOR A SUPPLIER?
